Topic · page 34 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,321–1,360 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

Eur J Heart Fail2 Oct 2024
Revascularization and Outcomes in Ischaemic Left Ventricular Dysfunction After Heart Failure Admission: The RevascHeart Study
Cohort study
JAMA Cardiol1 Oct 2024
Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial
Randomised controlled trial
Eur J Heart Fail30 Sep 2024
Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission
Secondary analysis
J Am Coll Cardiol30 Sep 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Secondary analysis
Circulation29 Sep 2024
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
Secondary analysis
J Am Coll Cardiol29 Sep 2024
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
Secondary analysis
J Am Coll Cardiol29 Sep 2024
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
Secondary analysis
Eur J Heart Fail26 Sep 2024
Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three‐headed monster
Research article
JACC Heart Fail25 Sep 2024
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis
Secondary analysis
J Am Coll Cardiol25 Sep 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF
Secondary analysis
Circulation25 Sep 2024
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial
Randomised controlled trial
Eur J Heart Fail24 Sep 2024
Cardio-Ocular Syndrome: Retinal Microvascular Changes in Acutely Decompensated Heart Failure
Cohort study
Eur J Heart Fail24 Sep 2024
Effect of Seasonal Influenza and COVID-19 Vaccination on Severity and Long-Term Outcomes of Patients with Heart Failure Decompensations
Cohort study
J Am Coll Cardiol24 Sep 2024
Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome
Cohort study
Circulation23 Sep 2024
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
Randomised controlled trial
Eur J Prev Cardiol23 Sep 2024
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis
Cohort study
Europace21 Sep 2024
Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study
Cohort study
JAMA19 Sep 2024
Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis
Meta-analysis
Nat Med19 Sep 2024
Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial
Randomised controlled trial
Eur J Heart Fail19 Sep 2024
In‐hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial
Secondary analysis
JACC CardioOncol17 Sep 2024
Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics–Related Cardiac Dysfunction
Cohort study
Eur Heart J17 Sep 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variants
Cohort study
J Am Coll Cardiol17 Sep 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Secondary analysis
Eur J Prev Cardiol13 Sep 2024
Electrocardiographic and morphological cardiac remodelling in competitive female athletes – a scoping review
Research article
Eur J Heart Fail12 Sep 2024
Timing of Sodium–Glucose Cotransporter 2 Inhibitor Initiation and Post-Discharge Outcomes in Acute Heart Failure with Diabetes: A Population-Based Cohort Study
Cohort study
JACC Heart Fail11 Sep 2024
Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF)
Randomised controlled trial
JACC Heart Fail11 Sep 2024
Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems
Cohort study
Circulation10 Sep 2024
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Guideline or statement
Eur J Heart Fail10 Sep 2024
Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
Cohort study
Eur J Heart Fail9 Sep 2024
Efficacy and Safety of Angiotensin Receptor–Neprilysin Inhibition in Heart Failure Patients with End-Stage Kidney Disease on Maintenance Dialysis: A Systematic Review and Meta-Analysis
Meta-analysis
Eur J Heart Fail9 Sep 2024
The Mayo ATTR-CM Score Versus Other Diagnostic Scores and Cardiac Biomarkers in Patients with Suspected Cardiac Amyloidosis
Diagnostic or prognostic study
Eur J Heart Fail6 Sep 2024
Impact of Age on Clinical Outcomes and Response to Serelaxin in Patients with Acute Heart Failure: An Analysis from the RELAX-AHF-2 Trial
Secondary analysis
Eur J Heart Fail3 Sep 2024
Metabolic Dysfunction and Incidence of Heart Failure Subtypes Among Black Individuals: The Jackson Heart Study
Cohort study
JACC Cardiovasc Imaging2 Sep 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial
Secondary analysis
Eur J Heart Fail1 Sep 2024
Sacubitril/Valsartan Reduces Incident Anaemia and Iron Therapy Utilization in Heart Failure: The PARAGON-HF Trial
Secondary analysis
Lancet1 Sep 2024
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis
Meta-analysis
Circulation1 Sep 2024
Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant–Level Analysis of 6 Randomized Clinical Trials
Meta-analysis
Eur Heart J1 Sep 2024
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial
Secondary analysis
N Engl J Med1 Sep 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Randomised controlled trial
J Am Coll Cardiol1 Sep 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Secondary analysis

All 1,928 Briefs in ExploreShowing Briefs 1,321–1,360 of 1,928, newest first